Bioray Biotech Co (ROCO:7561) Net Issuance of Preferred Stock : NT$0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Bioray Biotech Co's net issuance of preferred for the six months ended in Dec. 2024 was NT$0.0 Mil. The number is 0, which means that Bioray Biotech Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Bioray Biotech Co's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.0 Mil.

Bioray Biotech Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Bioray Biotech Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co Net Issuance of Preferred Stock Chart

Bioray Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Bioray Biotech Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial									-	-	-	-	-

Bioray Biotech Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Bioray Biotech Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioray Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846

Website

https://www.bio-ray.com.tw

Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co Headlines

No Headlines